scholarly journals Predictors of Recurrence in Early Hepatocellular Carcinoma Patients Treated with Surgical Resection

2021 ◽  
Author(s):  
Tzu‐Hsuan Cheng ◽  
Yu‐Ming Cheng ◽  
Chao‐Chuan Wu ◽  
I‐Shiang Tzeng ◽  
Chia‐Chi Wang
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Early Hepatocellular Carcinoma ◽  
Predictors Of Recurrence

scholarly journals Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

Hepatology ◽  
2000 ◽  
Vol 31 (4) ◽  
pp. 1019-1021 ◽  
Author(s):  
Josep M. Llovet ◽  
Jordi Bruix ◽  
Gregory J. Gores
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Early Hepatocellular Carcinoma

scholarly journals Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma

2012 ◽  
Vol 10 (1) ◽  
pp. 163 ◽  
Author(s):  
Gang Xu ◽  
Fu-zhen Qi ◽  
Jian-huai Zhang ◽  
Guo-feng Cheng ◽  
Yong Cai ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Surgical Resection ◽  
Meta Analysis ◽  
Early Hepatocellular Carcinoma

scholarly journals Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection

2021 ◽  
Vol Volume 8 ◽  
pp. 913-923
Author(s):  
Gu-Wei Ji ◽  
Ye Fan ◽  
Dong-Wei Sun ◽  
Ming-Yu Wu ◽  
Ke Wang ◽  
...  
Keyword(s):  
Machine Learning ◽  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Prognosis Prediction ◽  
Early Hepatocellular Carcinoma

Percutaneous radiofrequency ablation compared with surgical resection in the treatment of early hepatocellular carcinoma

2018 ◽  
Vol 37 (3) ◽  
pp. 286
Author(s):  
AshrafM Abd El-Kader ◽  
HazemE Ali ◽  
MagdyA Gad ◽  
BadawyA Abdel Aziz ◽  
Sharaf ElsayedAli Hassanien ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Surgical Resection ◽  
Percutaneous Radiofrequency Ablation ◽  
Early Hepatocellular Carcinoma

scholarly journals Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma

Cancer ◽  
2017 ◽  
Vol 123 (10) ◽  
pp. 1817-1827 ◽  
Author(s):  
Onur C. Kutlu ◽  
Jennifer A. Chan ◽  
Thomas A. Aloia ◽  
Yun S. Chun ◽  
Ahmed O. Kaseb ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Surgical Resection ◽  
Comparative Effectiveness ◽  
First Line ◽  
Early Hepatocellular Carcinoma

scholarly journals When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?

Medicine ◽  
2015 ◽  
Vol 94 (43) ◽  
pp. e1808 ◽  
Author(s):  
Po-Hong Liu ◽  
Chia-Yang Hsu ◽  
Yun-Hsuan Lee ◽  
Cheng-Yuan Hsia ◽  
Yi-Hsiang Huang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Surgical Resection ◽  
Early Hepatocellular Carcinoma

Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy versus Surgical Resection for Early Hepatocellular Carcinoma

2018 ◽  
Vol 84 (2) ◽  
pp. 282-288
Author(s):  
Peng-Sheng Yi ◽  
Min Huang ◽  
Ming Zhang ◽  
Liangliang Xu ◽  
Ming-Qing Xu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Surgical Resection ◽  
Transarterial Chemoembolization ◽  
Combined Therapy ◽  
Cochrane Library ◽  
Term Survival ◽  
Early Hepatocellular Carcinoma ◽  
Local Progression ◽  
Early Hcc

Both radiofrequency ablation (RFA) and surgical resection (SR) are radical treatment recommended for early hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is a palliative treatment for intermediate HCC, and TACE1RFA combined therapy is considered superior to TACE or RFA alone for management of early HCC. This systematic review compared the efficacy and safety of TACE1RFA combined therapy with SR for early HCC. Web of Science, PubMed, EMBASE, and the Cochrane Library were searched for literatures related with our topic. The primary endpoint was overall survival (OS), and the secondary endpoint was the recurrence-free survival (RFS) rate; safety was measured by the rate of major complications. The effect sizes of OS, RFS, and local progression rates were expressed by odds ratio (OR), while the effect size of complications was presented using relative risk. TACE1RFA combined therapy and SR had a similar 1-year OS rate [OR: 1.84; 95% confidence interval (CI): 0.82, 4.14; P > 0.05], 3-year OS rate (OR: 0.84; 95% CI: 0.43, 1.67; P > 0.05), 1-year RFS rate (OR: 0.77; 95% CI: 0.53, 1.11; P > 0.05), and 3-year RFS rate (OR: 0.88; 95% CI: 0.48, 1.42; P > 0.05) for early HCC. However, the 5-year OS rate (OR: 0.54; 95% CI: 0.40, 0.73; P < 0.05) and 5-year RFS rate (OR: 0.49; 95% CI: 0.27, 0.90; P < 0.05) were lower in patients with TACE1RFA than in those with SR. SR is associated with better long-term survival outcomes and a lower recurrence rate than TACE1RFA for patients with early HCC and is the optimal choice for patients with early HCC.

scholarly journals Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]

2021 ◽  
Vol Volume 8 ◽  
pp. 1297-1298
Author(s):  
Gu-Wei Ji ◽  
Ye Fan ◽  
Dong-Wei Sun ◽  
Ming-Yu Wu ◽  
Ke Wang ◽  
...  
Keyword(s):  
Machine Learning ◽  
Hepatocellular Carcinoma ◽  
Surgical Resection ◽  
Prognosis Prediction ◽  
Early Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document